COX-2: A target for colon cancer prevention

被引：256
|
作者：
Marnett, LJ
DuBois, RN
机构：
[1] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Ctr Mol Toxicol,Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Ctr Mol Toxicol,Dept Chem, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Ctr Mol Toxicol,Dept Med, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Ctr Mol Toxicol,Dept Cell Biol, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37232 USA
来源：
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY | 2002年 / 42卷
关键词：
cyclooxygenase; prostaglandins; NSAIDs; cancer; prevention;
D O I：
10.1146/annurev.pharmtox.42.082301.164620
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Disease prevention is one area that both public and governmental agencies strongly support owing to its potential for an improved lifestyle and a reduction in health care costs. In this review, we focus on the clinical development of one target for cancer prevention, the COX-2 enzyme. This provides an excellent example of how basic research in biochemistry and pharmacology can lead to translational studies and eventually to approval of a drug by the FDA for use as a chemopreventive agent in humans. It is hoped that, as the genome sequence: is understood more clearly, other targets will emerge that will provide even more effective drugs for future cancer prevention.
引用
收藏
页码：55 / +
页数：26
相关论文
共 50 条
  • [11] The role of COX-2 in intestinal inflammation and colorectal cancer
    D Wang
    R N DuBois
    Oncogene, 2010, 29 : 781 - 788
  • [12] The role of COX-2 in intestinal inflammation and colorectal cancer
    Wang, D.
    DuBois, R. N.
    ONCOGENE, 2010, 29 (06) : 781 - 788
  • [13] COX-2 inhibitors in cancer treatment and prevention, a recent development
    Xu, XC
    ANTI-CANCER DRUGS, 2002, 13 (02) : 127 - 137
  • [14] Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention
    Davies, G
    Martin, LA
    Sacks, N
    Dowsett, M
    ANNALS OF ONCOLOGY, 2002, 13 (05) : 669 - 678
  • [15] Hybrid fluorescent conjugates of COX-2 inhibitors: Search for a COX-2 isozyme imaging cancer biomarker
    Bhardwaj, Atul
    Kaur, Jatinder
    Sharma, Sai Kiran
    Huang, Zhangjian
    Wuest, Frank
    Knaus, Edward E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (01) : 163 - 168
  • [16] Prevention of colorectal cancer through the use of COX-2 selective inhibitors
    Richard M. Peek
    Cancer Chemotherapy and Pharmacology, 2004, 54 : S50 - S56
  • [17] Prevention of colorectal cancer through the use of COX-2 selective inhibitors
    Peek, RM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (Suppl 1) : S50 - S56
  • [18] Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer
    Ng, Kimmie
    Meyerhardt, Jeffrey A.
    Chan, Andrew T.
    Sato, Kaori
    Chan, Jennifer A.
    Niedzwiecki, Donna
    Saltz, Leonard B.
    Mayer, Robert J.
    Benson, Al B., III
    Schaefer, Paul L.
    Whittom, Renaud
    Hantel, Alexander
    Goldberg, Richard M.
    Venook, Alan P.
    Ogino, Shuji
    Giovannucci, Edward L.
    Fuchs, Charles S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (01):
  • [19] Cancer and cyclooxygenase-2 (COX-2) inhibition
    Evans, JF
    Kargman, SL
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (06) : 627 - 634
  • [20] Influencing COX-2 Activity by COX Related Pathways in Inflammation and Cancer
    Yu, Tingting
    Lao, Xingzhen
    Zheng, Heng
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2016, 16 (15) : 1230 - 1243
12345